{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T01:02:07Z","timestamp":1772499727566,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1038\/modpathol.2016.79","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T07:43:13Z","timestamp":1461310993000},"page":"685-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies"],"prefix":"10.1016","volume":"29","author":[{"given":"Andi K","family":"Cani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moaaz","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H","family":"Hovelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela J","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarred V","family":"Bratley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha E","family":"Rahrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar A","family":"Brice\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A","family":"Tomlins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5776-8366","authenticated-orcid":false,"given":"Rajesh C","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.79_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0161-6420(98)92107-8","article-title":"Malignant tumors of the orbit. analysis of the Florida Cancer Registry","volume":"105","author":"Margo","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1038\/modpathol.2016.79_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1006047803924","article-title":"Analysis of 24,444 surgical specimens accessioned over 55 years in an ophthalmic pathology laboratory","volume":"21","author":"Spraul","year":"1997","journal-title":"Int Ophthalmol"},{"key":"10.1038\/modpathol.2016.79_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnci\/djj248","article-title":"Rapidly increasing incidence of ocular non-Hodgkin lymphoma","volume":"98","author":"Moslehi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/modpathol.2016.79_bib4","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/modpathol.2016.79_bib5","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/S0161-6420(95)30764-6","article-title":"Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type","volume":"102","author":"White","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1038\/modpathol.2016.79_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.79_bib7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.79_bib8","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.79_bib9","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1038\/modpathol.2016.79_bib10","first-page":"2271","article-title":"Bcl-2\/JH rearrangements in benign lymphoid tissues with follicular hyperplasia","volume":"6","author":"Limpens","year":"1991","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2016.79_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.79_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cell.2011.09.035","article-title":"The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma","volume":"147","author":"Oricchio","year":"2011","journal-title":"Cell"},{"key":"10.1038\/modpathol.2016.79_bib13","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.79_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-717X-4-60","article-title":"Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis","volume":"4","author":"De Cicco","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1038\/modpathol.2016.79_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-8140(95)01658-9","article-title":"A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas","volume":"38","author":"Esik","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1038\/modpathol.2016.79_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0167-8140(00)00328-5","article-title":"Orbital lymphoma: radiotherapy outcome and complications","volume":"59","author":"Stafford","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1038\/modpathol.2016.79_bib17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijrobp.2011.12.097","article-title":"Risk of radiation retinopathy in patients with orbital and ocular lymphoma","volume":"84","author":"Kaushik","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/modpathol.2016.79_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior","volume":"65","author":"Suh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/modpathol.2016.79_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaophthalmol.2014.376","article-title":"Ocular adnexal follicular lymphoma: a multicenter international study","volume":"132","author":"Rasmussen","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1038\/modpathol.2016.79_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jamaophthalmol.2014.4644","article-title":"Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study","volume":"133","author":"Munch-Petersen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1038\/modpathol.2016.79_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/gcc.20463","article-title":"Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma","volume":"46","author":"Kim","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1038\/modpathol.2016.79_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/path.1386","article-title":"Typical genomic imbalances in primary MALT lymphoma of the orbit","volume":"200","author":"Matteucci","year":"2003","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.79_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.pas.0000249445.28713.88","article-title":"Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci","volume":"31","author":"Ruiz","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.79_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.humpath.2006.09.007","article-title":"Orbital marginal zone lymphomas: an immunohistochemical, polymerase chain reaction, and fluorescence in situ hybridization study","volume":"38","author":"Schiby","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2016.79_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2407-6-249","article-title":"Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma","volume":"6","author":"Tanimoto","year":"2006","journal-title":"BMC cancer"},{"key":"10.1038\/modpathol.2016.79_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neo.2015.03.004","article-title":"Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors","volume":"17","author":"Hovelson","year":"2015","journal-title":"Neoplasia"},{"key":"10.1038\/modpathol.2016.79_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.seminoncol.2014.05.002","article-title":"Molecular analysis for therapy choice: NCI MATCH","volume":"41","author":"Conley","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1038\/modpathol.2016.79_bib28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/1541-7786.MCR-14-0578","article-title":"Next-gen sequencing exposes frequent MED12 mutations and actionable therapeutic targets in phyllodes tumors","volume":"13","author":"Cani","year":"2015","journal-title":"Mol Cancer Res"},{"key":"10.1038\/modpathol.2016.79_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00428-014-1699-y","article-title":"Tumor evolution and progression in multifocal and paired non-invasive\/invasive urothelial carcinoma","volume":"466","author":"Warrick","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2016.79_bib30","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/modpathol.2016.79_bib31","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","article-title":"Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy","volume":"75","author":"McDaniel","year":"2015","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.79_bib32","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.humpath.2014.06.003","article-title":"HRAS mutations are frequent in inverted urothelial neoplasms","volume":"45","author":"McDaniel","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2016.79_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","article-title":"Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data","volume":"17","author":"Grasso","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2016.79_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.79_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fimmu.2014.00367","article-title":"Toll-like receptors and cancer: MYD88 mutation and inflammation","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol"},{"key":"10.1038\/modpathol.2016.79_bib36","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood-2013-04-496893","article-title":"EZH2 mutations are frequent and represent an early event in follicular lymphoma","volume":"122","author":"Bodor","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.79_bib37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/leu.2010.311","article-title":"EZH2 Y641 mutations in follicular lymphoma","volume":"25","author":"Bodor","year":"2011","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2016.79_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.79_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.79_bib40","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","article-title":"Mutations in linker histone genes HIST1H1 B, C, D and E, OCT2 (POU2F2), IRF8 and ARID1A underlying the pathogenesis of follicular lymphoma","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.79_bib41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2012.09176.x","article-title":"MYD88 somatic mutations in MALT lymphomas","volume":"158","author":"Li","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2016.79_bib42","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V91.7.2381","article-title":"Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets","volume":"91","author":"Tierens","year":"1998","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.79_bib43","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2016.79_bib44","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2016.79_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.79_bib46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.79_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/leu.2012.257","article-title":"IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia\/lymphoplasmacytic lymphomas","volume":"27","author":"Gachard","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2016.79_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","article-title":"Lymphoma of the ocular adnexa: a study of 353 cases","volume":"31","author":"Ferry","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.79_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAP.0b013e3181e4abdb","article-title":"Ocular adnexal lymphomas: a review","volume":"17","author":"McKelvie","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2016.79_bib50","doi-asserted-by":"crossref","first-page":"e0131458","DOI":"10.1371\/journal.pone.0131458","article-title":"Clinicopathological analysis of ocular adnexal extranodal marginal Zone B-cell lymphoma with IgG4-positive cells","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1038\/modpathol.2016.79_bib51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ajh.23490","article-title":"Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas","volume":"88","author":"Zhu","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2016.79_bib52","first-page":"436","article-title":"Mutation analysis of NF-kappaB signal pathway-related genes in ocular MALT lymphoma","volume":"5","author":"Liu","year":"2012","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1038\/modpathol.2016.79_bib53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MOH.0000000000000051","article-title":"The origin and targeting of mucosa-associated lymphoid tissue lymphomas","volume":"21","author":"Martinez-Climent","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"10.1038\/modpathol.2016.79_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-004-0914-3","article-title":"Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa","volume":"84","author":"Lee","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1038\/modpathol.2016.79_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-3768.2008.01478.x","article-title":"Ophthalmic lymphoma: epidemiology and pathogenesis","volume":"87 Thesis 1","author":"Sjo","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1038\/modpathol.2016.79_bib56","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nrc3929","article-title":"Hijacked in cancer: the KMT2 (MLL) family of methyltransferases","volume":"15","author":"Rao","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2016.79_bib57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.79_bib58","doi-asserted-by":"crossref","first-page":"e1001378","DOI":"10.1371\/journal.pgen.1001378","article-title":"GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma","volume":"7","author":"Smedby","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1038\/modpathol.2016.79_bib59","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","article-title":"Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2016.79_bib60","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"key":"10.1038\/modpathol.2016.79_bib61","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2016.79_bib62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.79_bib63","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1038\/modpathol.2016.79_bib64","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.chembiol.2014.09.017","article-title":"EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation","volume":"21","author":"Bradley","year":"2014","journal-title":"Chem Biol"},{"key":"10.1038\/modpathol.2016.79_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers","volume":"21","author":"Bitler","year":"2015","journal-title":"Nat Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201679","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222021366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222021366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:56:22Z","timestamp":1760230582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222021366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":65,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0893395222021366"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.79","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.79","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}